BioMed Central
Introduction of a hexavalent vaccine containing acellular pertussis into the national immunization program for infants in Peru: a cost-consequence analysis of vaccination coverage
By Janice Seinfeld,
1 days agoBy Janice Seinfeld,
1 days agoRead in NewsBreak
Comments /
Add a Comment
YOU MAY ALSO LIKE
M Henderson6 days ago
Uncovering Florida22 days ago
Arizona Luminaria1 day ago
André Emilio14 days ago
The HD Post16 days ago
BioMed Central2 days ago
Alameda Post16 days ago
BioMed Central1 day ago
Uncovering Florida7 days ago
Alameda Post15 days ago
Jacksonville Today12 days ago
David Heitz23 days ago
WyoFile9 days ago
Northern Kentucky Tribune20 days ago
Jacksonville Today9 days ago
The HD Post24 days ago
Alameda Post19 days ago
WyoFile8 days ago
David Heitz3 days ago
Declutterbuzz20 days ago
The HD Post7 days ago
David Heitz8 days ago
Uncovering Florida26 days ago
Northern Kentucky Tribune4 days ago
Get updates delivered to you daily. Free and customizable.
It’s essential to note our commitment to transparency:
Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. As a platform hosting over 100,000 pieces of content published daily, we cannot pre-vet content, but we strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation.
Comments / 0